title: [Effect of Shexiang Baoxin pill on coronary vasodilation by analysis of coronary angiography].
abstract: OBJECTIVE
  To evaluate the effect of Shexiang Baoxin Pill (SBP) on coronary vasodilation by analysis of coronary angiography (CAG).
  
  
  METHODS
  A consecutive cohort of 300 patients who underwent CAG between January 2013 and July 2013 were recruited and randomly assigned to 2 groups before operation. Patients in the SBP group sublingually took SBP, while those in the control group sublingually took placebos. All patients repeatedly underwent CAG 5 min after administration. The vascular diameter was calculated by quantitative angiography analysis method. The diameter of the left anterior descending coronary artery was measured in patients whose coronary arteries had no stenosis. The narrowest vascular diameter was measured in patients whose coronary arteries had stenosis. The heart rate, blood pressure, and the vascular diameter were compared between before and after administration in the two groups.
  
  
  RESULTS
  In the two groups, there was no significant difference in changes of heart rate, systolic pressure, or diastolic pressure between before and after administration (all P > 0.05). There were 64 patients with normal CAG in the two groups, 30 in the control group and 34 in the SBP group. CAG showed there were 236 patients with stenotic coronary artery, 110 in the control group and 126 in the SBP group. The vascular diameter was obviously larger in patients in the SBP group with normal or abnormal CAG after administration (all P < 0.01). It was also obviously larger than that of the control group after administration (P < 0.05, P < 0.01).
  
  
  CONCLUSIONS
  SBP could dilate both normal coronary artery and lesioned coronary arteries, but did not lead to fastened heart rate and decreased blood pressure.
authors: Xian-Zhao
authors: XZ
authors: Zhang
authors: Ya-Min
authors: YM
authors: Hou
authors: Zhi-Hong
authors: ZH
authors: Ou
mesh_terms: D001794:Blood Pressure; D017023:Coronary Angiography; D003331:Coronary Vessels / Q000187:drug effects; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006339:Heart Rate; D006801:Humans; D013607:Tablets; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D004365:Drugs, Chinese Herbal; D013607:Tablets; C526712:shexiang baoxin